MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from ppas
$7,125K
Proceeds from issuance of
common stock under...
$100K
Net cash provided by
financing activities
$6,276K
Canceled cashflow
$949K
Net decrease in cash
and cash...
-$41,928K
Canceled cashflow
$6,276K
Stock-based compensation
$5,434K
Accounts payable and
accrued expenses
$2,804K
Prepaid expenses and
other assets
-$1,128K
Financing costs related to
ppas
$742K
Change in fair value of
ppas liability
$406K
Depreciation and
amortization
$373K
Right-of-use assets and lease
liabilities, net
$344K
Commitment fee under sepa
$282K
Loss on disposal of
property and equipment
-$185K
Payment of financing
costs related to...
$897K
Payments for taxes
related to net...
$52K
Net cash used in
operating activities
-$48,204K
Canceled cashflow
$11,698K
Net loss
-$59,607K
Change in fair value of
warrant liability
-$295K
Back
Back
Cash Flow
source: myfinsight.com
BioAtla, Inc. (BCAB)
BioAtla, Inc. (BCAB)